@article{article, title = {{Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial}}, publisher = {{Informa UK Limited}}, url = {{http://dx.doi.org/10.1080/09546634.2023.2200866 }}, year = {{2023}}, month = {{4}}, author = {{Flohr C and Cork MJ and Ardern-Jones MR and Eichenfield LF and Barbarot S and Feeney C and Rojo R and Lazariciu I and Nesnas J}}, doi = {{10.1080/09546634.2023.2200866}}, volume = {{34}}, journal = {{Journal of Dermatological Treatment}}, issue = {{1}}, note = {{Accessed on 2025/05/28}}}